Sandbox drug template: Difference between revisions

Jump to navigation Jump to search
Rim Halaby (talk | contribs)
No edit summary
Rim Halaby (talk | contribs)
No edit summary
 
(3 intermediate revisions by the same user not shown)
Line 2: Line 2:
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF;" align=center | [[XXXXX|{{fontcolor|#2B3B44|XXXXX}}]]
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF;" align=center | [[XXXXX|{{fontcolor|#2B3B44|XXXXX}}]]
|-
|-
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | ZZZZZ<sup>®</sup> FDA Package Insert
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | YYYYY<sup>®</sup> FDA Package Insert
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ indications and usage|Indications and Usage]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Lopressor black box warning|{{fontcolor|#FF0000|Black Box Warning}}]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ dosage and administration|Dosage and Administration]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ dosage and administration|Dosage and Administration]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ dosage forms and strengths|Dosage Forms and Strengths]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ dosage forms and strengths|Dosage Forms and Strengths]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ indications and usage|Indications and Usage]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ contraindications|Contraindications]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ contraindications|Contraindications]]
Line 23: Line 25:
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ description|Description]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ description|Description]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ mechanism of action|Mechanism of Action]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ clinical pharmacology|Clinical Pharmacology]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ clinical pharmacology|Clinical Pharmacology]]
Line 36: Line 40:
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ labels and packages|Labels and Packages]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ labels and packages|Labels and Packages]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ pill images|Pill Images]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ pill images and characteristics|Pill Images]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ price|Price]]
|-
|-
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | [[XXXXX (patient information)|{{fontcolor|#2B3B44|Patient Information}}]]
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | [[XXXXX (patient information)|{{fontcolor|#2B3B44|Patient Information}}]]
|-
|-
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on XXXXX
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | [http://clinicaltrials.gov/search/open/condition=XXXXX {{fontcolor|#2B3B44|Clinical Trials}}]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov]
|-
|-
|}
|}

Latest revision as of 16:50, 14 March 2014